Search For "bharat biotech covaxin"
Bharat Biotech's Covaxin shows 77.8 pc efficacy in Phase III trials, say s
Updated : 4 years, 8 months ago IST
New Delhi [India], June 22 (ANI): Bharat Biotech's Covaxin has shown 77.8 per cent efficacy after the Subject Expert Committee (SEC) under the drug regulator reviewed its Phase III trials data on Tuesday, according to sources.
Read More
Bharat Biotech has submitted Covaxin's Phase III trial data to DCGI: Govt
Updated : 4 years, 8 months ago IST
New Delhi [India], June 21 (ANI): The Hyderabad-based COVID vaccine manufacturing company Bharat Biotech submitted data from the Phase III clinical trials of Covaxin to Drugs Controller General of India (DCGI) over the weekend, according to government sources.
Read More
Rs 150 per dose is not sustainable in long run: Bharat Biotech on Centre's
Updated : 4 years, 9 months ago IST
Hyderabad (Telangana) [India], June 15 (ANI): Indigenous COVID-19 vaccine maker Bharat Biotech on Tuesday said the supply price of Covaxin to the Government of India at Rs 150 per dose is a non-competitive price and not sustainable in the long run, hence a higher price in private markets is
Read More
COVAXIN phase 3 full trial data will be made public in July: Bharat Biotec
Updated : 4 years, 9 months ago IST
New Delhi [India], June 9 (ANI): Hyderabad-based vaccine manufacturer Bharat Biotech, which is carrying out its phase 3 trial will publish the data in July following that the company will be applying for the full licensure of COVAXIN.
Read More
Brazil approves proposal to import Bharat Biotech's Covaxin with regulatio
Updated : 4 years, 9 months ago IST
Hyderabad [Telangana] , June 5 (ANI): Brazil has approved the import of Bharat Biotech manufactured COVID-19 vaccine Covaxin into the country with regulations, informed ANVISA on Friday.
Read More
Bihar: Covaxin trials on children begin at Patna's AIIMS
Updated : 4 years, 9 months ago IST
Patna (Bihar) [India], June 3 (ANI): Patna's All India Institute of Medical Sciences (AIIMS) has started the paediatric trials for the COVID-19 vaccine manufactured by the Bharat Biotech, Covaxin.
Read More
Bharat Biotech to scale up Covaxin production, eyes 200 mn doses annually
Updated : 4 years, 9 months ago IST
New Delhi [India], May 20 (ANI): Amid the growing demand for vaccines in the country, Hyderabad-based Bharat Biotech has announced ramping up of additional manufacturing capacities for Covaxin at Chiron Behring Vaccines in Gujarat's Ankleshwar.
Read More
Bharat Biotech supplying vaccines directly to 18 states since May 1
Updated : 4 years, 10 months ago IST
New Delhi [India], May 11 (ANI): Bharat Biotech on Tuesday informed that the firm has been supplying its COVID-19 vaccine Covaxin directly to 18 states since May 1.
Read More
After SII, Bharat Biotech cuts Covaxin price for states to Rs 400 per dose
Updated : 4 years, 10 months ago IST
New Delhi [India], April 30 (ANI): Bharat Biotech on Thursday announced it will supply its COVID-19 vaccine--Covaxin to state governments at Rs 400 per dose.
Read More
'A powerful example for all Indians': Bharat Biotech after PM Modi receive
Updated : 5 years ago IST
Hyderabad (Telangana) [India], March 1 (ANI): Bharat Biotech International Limited (BBIL), the Indian vaccines and bio-therapeutics manufacturer that developed the country's indigenous COVID-19 vaccine, Covaxin, on Monday welcomed Prime Minister Narendra Modi's gesture of taking the first do
Read More
Bharat Biotech dispatches COVID-19 vaccine Covaxin to 11 cities, donates 1
Updated : 5 years, 2 months ago IST
Hyderabad (Telangana) [India], January 13 (ANI): The Bharat Biotech International Limited (BBIL) has announced the successful air-shipment of its COVID-19 vaccine 'Covaxin' to 11 cities in the country in the early hours of Wednesday.
Read More
Our goal is to provide global access of Covaxin to needy population: Dr E
Updated : 5 years, 2 months ago IST
Hyderabad (Telangana) [India], January 4 (ANI): The emergency use approval for Covaxin is "a giant leap for innovation and novel product development" in India and the "goal is to provide global access to populations that need it the most", Bharat Biotech chairman and managing director Dr
Read More